Physician profile
Ryan D Williams
NPI 1770818361
$3,192.34
in general payments reported to CMS, 2019-2025
18 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $630 · 2022: $876 · 2023: $455 · 2024: $720 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,013.83 | 2021-2025 | |
| Boston Scientific Corporation | $639.29 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $636.07 | 2022-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $346.27 | 2021-2024 | Proclaim, Eterna |
| Nevro Corp. | $117.26 | 2021-2022 | |
| Medtronic, INC. | $75.06 | 2021-2025 | Inceptiv, Synchromedii |
| Pfizer INC. | $70.72 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $55.54 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $51.32 | 2023-2025 | Ajovy, Austedo Xr |
| Amgen INC. | $50.07 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $31.56 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.37 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.59 | 2023 | Quviviq |
| Radius Health, INC. | $14.17 | 2022 | |
| Lilly USA, LLC | $13.73 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $13.36 | 2024 | Xeomin |
| Redhill Biopharma INC. | $13.19 | 2021 | |
| Spr Therapeutics, INC | $10.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.